Postdoc in translational research of liver cirrhosis and cancer
We are seeking postdoc fellows experienced in liver cell biology and/or clinical hepatology to participate in translational research projects for clinical outcome prediction, disease classification, and therapeutic target discovery in liver cirrhosis and cancer. The candidates will work with multidisciplinary team of physician scientists, basic biologists, computational biologists, and clinicians at the institution and national/international collaborating institutions, and have ample opportunities of scientific publications and presentations. The lab is a part of the NIH/NCI-supported Simmons Comprehensive Cancer Center, housing cutting-edge research facilities and world-class scientists, located in the Dallas metropolitan area, one of the nation’s fastest growing cities.
Liver Tumor Translational Research Program (Hoshida lab) is a national leader in molecular classification, prognostic prediction, molecular targeted therapies, and chemoprevention in liver cirrhosis and cancer, leading several international translational liver cirrhosis/cancer genomics projects, including Precision Liver Cancer Prevention Consortium, utilizing high-throughput omics technologies and integrative clinical and cross-species systems biology analysis over the past decade. The current focuses of the Program include liver cancer risk-predictive molecular biomarkers specific to clinical contexts (e.g., geographic region, liver disease etiology, and patient race/ethnicity), individual risk-stratified personalized cancer screening based on cost-effectiveness, chemoprevention target discovery, radiogenomics, molecular subtype-guided liver cancer therapies, and informatics methodology and software by utilizing patient-derived tissues/cells, liquid biopsy of circulating biomolecules, single-cell omics, molecular digital spatial tissue profiling, clinical diagnostic platforms, nanomedicine technologies, and high-power computation.
Requirements:
- Highly motivated MD, PhD, MD/PhD or equivalent in molecular biology, systems biology, or other relevant areas.
- Expertise in pathogenic liver cell biology and molecular biology techniques.
- Experience in high-throughput omics assays and data analysis.
- Quick learner of new technologies and analytical methods.
- Strong interpersonal skills and a track record of collaborative work in multidisciplinary research environment.
To apply, please e-mail CV, cover letter, and contact information of 3 references to:
Yujin.Hoshida (at) UTSouthwestern.edu
Yujin Hoshida, MD, PhD
Director, Liver Tumor Translational Research Program
CPRIT Scholar in Cancer Research
Harold C. Simmons Comprehensive Cancer Center
Associate Professor of Medicine
Division of Digestive and Liver Diseases
Department of Internal Medicine
University of Texas Southwestern Medical Center
We are seeking postdoc fellows experienced in liver cell biology and/or clinical hepatology to participate in translational research projects for clinical outcome prediction, disease classification, and therapeutic target discovery in liver cirrhosis and cancer. The candidates will work with multidisciplinary team of physician scientists, basic biologists, computational biologists, and clinicians at the institution and national/international collaborating institutions, and have ample opportunities of scientific publications and presentations. The lab is a part of the NIH/NCI-supported Simmons Comprehensive Cancer Center, housing cutting-edge research facilities and world-class scientists, located in the Dallas metropolitan area, one of the nation’s fastest growing cities.
Liver Tumor Translational Research Program (Hoshida lab) is a national leader in molecular classification, prognostic prediction, molecular targeted therapies, and chemoprevention in liver cirrhosis and cancer, leading several international translational liver cirrhosis/cancer genomics projects, including Precision Liver Cancer Prevention Consortium, utilizing high-throughput omics technologies and integrative clinical and cross-species systems biology analysis over the past decade. The current focuses of the Program include liver cancer risk-predictive molecular biomarkers specific to clinical contexts (e.g., geographic region, liver disease etiology, and patient race/ethnicity), individual risk-stratified personalized cancer screening based on cost-effectiveness, chemoprevention target discovery, radiogenomics, molecular subtype-guided liver cancer therapies, and informatics methodology and software by utilizing patient-derived tissues/cells, liquid biopsy of circulating biomolecules, single-cell omics, molecular digital spatial tissue profiling, clinical diagnostic platforms, nanomedicine technologies, and high-power computation.
Requirements:
- Highly motivated MD, PhD, MD/PhD or equivalent in molecular biology, systems biology, or other relevant areas.
- Expertise in pathogenic liver cell biology and molecular biology techniques.
- Experience in high-throughput omics assays and data analysis.
- Quick learner of new technologies and analytical methods.
- Strong interpersonal skills and a track record of collaborative work in multidisciplinary research environment.
To apply, please e-mail CV, cover letter, and contact information of 3 references to:
Yujin.Hoshida (at) UTSouthwestern.edu
Yujin Hoshida, MD, PhD
Director, Liver Tumor Translational Research Program
CPRIT Scholar in Cancer Research
Harold C. Simmons Comprehensive Cancer Center
Associate Professor of Medicine
Division of Digestive and Liver Diseases
Department of Internal Medicine
University of Texas Southwestern Medical Center